PharmaBoardroom

Saudi Arabia: Significant Steps Towards Clinical Trial Hub Status

Clinical trials provide a pathway to innovation for clinicians and patients in countries like Saudi Arabia and form a key element of the country’s…

Hong Kong: HKEX Biotech IPOs in the First Half of 2021

Three years after the Hong Kong Stock Exchange (HKEX) introduced reforms to allow and support the listing of pre-profit biotech companies, it has…

Süha Taşpolatoğlu – CEO, Abdi Ibrahim

Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s ambitious bet on biosimilars, their…

Hatice Öncel – CEO, Ilko Pharmaceuticals

Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel explains the company’s investment in…

China Pharma Roundup: Sinopharm Tops Brand Value Rankings;…

The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant Simcere and German biotech Vivoryon in…

Senthil Sockalingam – Head of IQVIA Biotech, JAPAC &…

IQVIA Biotech JAPAC’s Dr Senthil Sockalingam outlines the evolving needs of the flood of early-stage drug discovery ventures in Asia, how biotechs…

Building a Globally Competitive Innovation Ecosystem in Singapore

Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest some USD 20 billion over the next 5…

Colombia Pharma News: $25 million US Cannabis Deal; COVID-Related…

The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced…

Fayad Al Dandashi – CEO, Tamer HealthCare

Dr Fayad Al Dandashi, CEO of Tamer HealthCare, a leading Saudi healthcare company, discusses how the group aims to benefit from Saudi Arabia’s…

Hussein El Hakim – Managing Director & General Manager…

Hussein El Hakim, managing director for Bayer Saudi Arabia and general manager for its pharmaceuticals division in the country, discusses the…

Saudi’s Centralised Procurement Body: Pharma Leaders Have…

As part of Saudi Arabia’s ambitious ‘Vision 2030’ economic transformation plan, the country has centralised the public procurement of…

Ayman Tamer – Chairman & Managing Partner, Tamer Group

Aymen Tamer, chairman and managing partner of historic Saudi healthcare firm Tamer Group, outlines how, informed by Saudi’s Vision 2030, the company…

Tagged with BI